Press Releases - 2023-10-06

Date	Title	Company
06-Oct-2023	La Corte suprema delle Bahamas si pronunzia a favore del Committee to Restore Nymox Shareholder Value: ordina assemblea degli azionisti ed emette ingiunzione di congelamento delle azioni del CEO	Businesswire
06-Oct-2023	Hooggerechtshof van de Bahama's spreekt zich uit ten gunste van Committee to Restore Nymox Shareholder Value: geeft bevel tot aandeelhoudersvergadering en veroordeelt tot bevriezing CEO-aandelen	Businesswire
06-Oct-2023	La Cour suprême des Bahamas donne raison au Committee to Restore Nymox Shareholder Value : ordonnant la tenue d’une assemblée des actionnaires et accordant une injonction pour geler les actions du président-directeur général	Businesswire
06-Oct-2023	Professor Brian Cox leads action-packed Brooklands Innovation Academy 2023	Brooklands Innovation Academy
06-Oct-2023	Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America	Moberg Pharma
06-Oct-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
06-Oct-2023	Vulvodynia Treatment Market: Soaring Towards an US$ 8 Billion Valuation by 2028 \| Future Market Insights,Inc.	MARKITWIRED
06-Oct-2023	Zika Virus Testing Market: Unveiling Vigilance on the Path to US$ 6.8 Million by 2033 -FMI Projection	MARKITWIRED
06-Oct-2023	Rare Neurological Disease Treatment Market Set to Reach US$ 19.795 Billion by 2032	MARKITWIRED
06-Oct-2023	Rare Inflammatory Disease Treatment Market Soars to a Valuation of US$ 17,335.8 Million by 2028	MARKITWIRED
06-Oct-2023	Bayer to partner with Twist Bioscience to accelerate drug discovery	Bayer
06-Oct-2023	Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery	Merck
06-Oct-2023	AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline	AbbVie
06-Oct-2023	New data at WMS 2023 reaffirm long-term efficacy of Nexviazyme® (avalglucosidase alfa) for the treatment of Pompe disease	Sanofi
06-Oct-2023	Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease	Boehringer Ingelheim
06-Oct-2023	ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons	Businesswire
06-Oct-2023	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases	Pfizer
06-Oct-2023	EYLEA® HD (AFLIBERCEPT) INJECTION 8 MG TWO-YEAR RESULTS FROM PIVOTAL PULSAR TRIAL IN WET AGE-RELATED MACULAR DEGENERATION PRESENTED AT EURETINA	Regeneron
06-Oct-2023	Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science	IQVIA
06-Oct-2023	Surface Plasmon Resonance Market Projected to Reach US$ 1807.7 Million by 2032 \| FMI	MARKITWIRED